Alveolar hemorrhage in systemic lupus erythematosus

Authors: GOGIA, Atul; KAKAR, Atul; SUREKA, Rohit; BYOTRA, S.; PRAKASH, Ved

Source: APLAR Journal of Rheumatology, Volume 10, Number 4, December 2007 , pp. 322-325(4)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Alveolar haemorrhage is a catastrophic though rare complication of systemic lupus erythematosus (SLE) and is associated with a high mortality rate with most studies showing a mortality of 23-92%. The treatment modalities available for such complications are pulse cyclophosphamide therapy with steroids and plasmapheresis in patients who do no respond to the above treatment. We report here a case of SLE with alveolar haemorrhage that despite being on immunomodulatory therapy developed alveolar haemorrhage and did not respond to plasmapheresis.

Keywords: clinical aspects; drug treatment; systemic lupus erythematous

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1479-8077.2007.00317.x

Publication date: 2007-12-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page